(Q36466102)

14 August 2017

Late immune and haemopoietic functions in plasmacytoma-bearing mice cured by melphalan (English)

1 reference

14 August 2017

Sagi O

1

1 reference

14 August 2017

Witz IP

2

1 reference

14 August 2017

Ramot B

3

1 reference

14 August 2017

Sahar E

4

1 reference

14 August 2017

Douer D

5

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 March 1988

1 reference

British Journal of Cancer

14 August 2017

1 reference

14 August 2017

57

1 reference

14 August 2017

3

1 reference

14 August 2017

271-276

1 reference

Long-term bone marrow damage in experimental systems and in patients after radiation or chemotherapy.

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246520

Assessment of cytotoxic injury to bone marrow

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246520

Mechanisms of tumor progression

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246520

A comparison of the incidence of the myelodysplastic syndrome and acute myeloid leukaemia following melphalan and cyclophosphamide treatment for myelomatosis. A report to the Medical Research Council's working party on leukaemia in adults

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246520

The effect of immunosuppressive chemotherapy on immune function in patients with malignant disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246520

Pre-B and B cells in children on leukaemia remission maintenance treatment

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246520

T cell growth factor: parameters of production and a quantitative microassay for activity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246520

A delayed complication of cancer therapy--cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246520

A primary stem cell lesion in experimental chronic hypoplastic marrow failure

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246520

Increase in the effectiveness of melphalan therapy with progression of MOPC-315 plasmacytoma tumor growth.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246520

Late effects of chemotherapy on hematopoietic progenitor cells

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246520

Importance of the concomitant presence of palpable MOPC-315 tumor in stimulation of splenocytes by C-type MOPC-315 virus in vitro

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246520

Toxicity of antineoplastic agents in man, chromosomal aberrations antifertility effects, congenital malformations, and carcinogenic potential.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246520

Natural host defence during oncogenesis. NK activity and dimethylbenzanthracene carcinogenesis

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246520

21 September 2018

Immunosuppressive drugs

1 reference

12 December 2020

A miniaturized mouse mixed leukocyte culture in serum-free and mouse serum supplemented media

1 reference

12 December 2020

An animal model of chronic aplastic marrow failure. I. Late marrow failure after busulfan

1 reference

12 December 2020

Multisystem stem cell failure after apparent recovery from alkylating agents

1 reference

12 December 2020

"Stromal" and hemopoietic stem cell abnormalities in long-term cultures of marrow from busulfan-treated mice

1 reference

12 December 2020

Decreased immunoglobulin production by a human lymphoid cell line following melphalan treatment

1 reference

12 December 2020

Abnormal monoclonal antibody-defined helper/suppressor T-cell subpopulations in multiple myeloma: relationship to treatment and clinical stage

1 reference

12 December 2020

Pre-B-cells in normal human bone marrow and in bone marrow from patients with leukemia in remission: persistent quantitative differences and possible expression of cell surface IgM in vitro

1 reference

12 December 2020

Biologic effects of prolonged melphalan treatment of murine long-term bone marrow cultures and interleukin 3-dependent hematopoietic progenitor cell lines

1 reference

12 December 2020

Abnormal clonogenic potential of T cells from multiple myeloma patients

1 reference

12 December 2020

Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience

1 reference

12 December 2020

Effect of Intraperitoneal Pristane on Established Immunity to the Adj-PC-5 Plasmacytoma2

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1988.58

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

3258523

1 reference